About Noblegen
Noblegen is a company based in Peterborough (Canada) founded in 2013 was acquired by SolarBiotech in July 2023. It operates as a Commission-Based. Noblegen has raised $18.51 million across 3 funding rounds from investors including HHS and SolarBiotech. Noblegen offers products and services including Online Slots. Noblegen operates in a competitive market with competitors including Novozymes, Evelo Biosciences, Seed, Seres Therapeutics and Enzymotec, among others.
- Headquarter Peterborough, Canada
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website noblegen.com
- Social LinkedIn X
- Acquired by SolarBiotech (Jul 2023)
- Total Equity Funding$18.51M (USD)
in 3 rounds
- Latest Funding Round$18.51M (USD), Series B
May 2019
- InvestorsHHS
& 1 more
- Acquired bySolarBiotech
(Jul 2023)
Products & Services of Noblegen
Noblegen offers a comprehensive portfolio of products and services, including Online Slots.
Online slots are provided with easy winning opportunities.
Funding Insights of Noblegen
Noblegen has successfully raised a total of $18.51M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $18.51 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.51M
- Total Rounds 3
- Last Round Series B — $18.51M
- First Round $272,215
(Sep 2013)
- Investors Count 1
All 3 funding rounds of Noblegen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $18.51M | Series B | – | – | – |
| Jun 2016 | – | Series A | – | – | – |
| Sep 2013 | $272,215 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Noblegen
Noblegen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and SolarBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Modular plant architectures are produced for scaling laboratory equipment. | 2019 | solarbiotech.com | Bristol, United States |
Investor details for Noblegen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Noblegen
14 people are tracked at Noblegen (4 in leadership, 10 in board & advisors).
| Name | Role | Group |
|---|---|---|
Bob Hill | CFO | Leadership |
Peeyush Maheshwari | VP, Product Development | Leadership |
Adam Noble | CEO | Leadership |
Hugh Williams | VP, Eunite Strategy & Commercial | Leadership |
David Abramson | Board Member | Board & advisors |
Peter Erickson | Board Member | Board & advisors |
Nora Fortune | Board Member | Board & advisors |
Jim Kirkwood | Board Member | Board & advisors |
Gwyn Morgan | Board Member | Board & advisors |
Kathleen Ramsay | Board Member | Board & advisors |
Barney Easterling | Advisor | Board & advisors |
Donald Solman | Board Member | Board & advisors |
David Rankin | Advisor | Board & advisors |
Nigel Hughes | Advisor | Board & advisors |
Complete people profiles for Noblegen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Noblegen
4 dated milestones of Noblegen across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Noblegen is founded.
- Funding First funding round of $272K.
- Funding Latest funding round, Series B, of $18.5M.
- Exit Acquired by SolarBiotech.
Competitors of Noblegen
Noblegen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Evelo Biosciences, Seed, Seres Therapeutics and Enzymotec, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novozymes.com | 2000 | Bagsvaerd, Denmark | – | 6,781 | Biosolutions and enzymes are developed for biotechnology applications across industries. | |
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| seed.com | 2016 | Los Angeles, United States | $40.62M | – | Synbiotics are developed for simulating the gut microbiome. | |
| serestherapeutics.com | 2010 | Cambridge, United States | $257.13M | 332 | Microbiome therapeutics are developed to address diverse diseases. | |
| enzymotec.com | 1998 | Kfar Saba, Israel | $21M | – | Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses. | |
| maatpharma.com | 2014 | Lyon, France | $42.3M | – | Microbiome therapies are developed for treating intestinal dysbiosis diseases. | |
| rebiotix.com | 2011 | Roseville, United States | $29.3M | – | Microbiota restoration therapies are developed for gastrointestinal infections. | |
| 4dpharmaplc.com | 2008 | Manchester, United Kingdom | – | 106 | Drugs from gut bacteria are developed for multiple diseases. | |
| advancedenzymes.com | 1989 | Thane, India | – | 689 | Enzymes are manufactured for nutrition, food, feed, and textile industries. | |
| genomecom.co.kr | 2015 | Seongnam-si, South Korea | – | – | Microbiome-based immuno-oncology drugs are developed using proprietary technology. |
Detailed competitors of Noblegen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Noblegen
Complete news archive for Noblegen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Noblegen
10 companies that operate in the same segment as Noblegen (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | – | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 80.12 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Noblegen
Noblegen was founded in 2013.
Noblegen is headquartered in Peterborough, Canada. It is registered at Peterborough, Ontario, Canada.
Noblegen is a funded company, having raised a total of $18.51M across 3 funding rounds to date. The company's 1st funding round was a Grant of $272.22K, raised on Sep 2013.
Noblegen is managed as a direct online slots platform offering gaming services without intermediaries. It is focused on the online gambling sector, providing a variety of slot games with high payout rates and bonuses. Solutions include seamless deposit and withdrawal systems using True Wallet, ensuring accessibility even for users with minimal capital. The platform is supported by a certified API system for transparency and security, catering to a wide range of players seeking entertainment and real money rewards.
Noblegen's top competitors include Novozymes, Seres Therapeutics and Seed.
Noblegen offers Online Slots.
Noblegen has 2 investors. Key investors include HHS, and SolarBiotech.
Yes. Noblegen was acquired by SolarBiotech in July 2023.